This study is testing whether a drug called atacicept can help control IgA nephropathy, a kidney disease. It will see if the drug safely reduces protein in the urine and slows the decline of kidney function in adults who are already on standard medication. The trial involves a tw…
Phase: PHASE3 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC